Renal Denervation: 60 Second Insights

Published: 22 March 2019

  • Views:

    Views Icon 5094
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!

More from this programme

Part 1

Thinking about patient preference, what role does RDN have in blood pressure control?

Part 2

What role do you see for renal denervation in control of blood pressure in your patients?

Part 3

Where does renal denervation fit in your current clinical practice?

Part 4

What are the biggest barriers to blood pressure control in your patients?

Part 7

How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?

Part 8

Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?

Part 9

Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?

Part 10

Can you give an overview of the RDN SPYRAL clinical trial program?

Part 11

Thinking about compliance, what are the advantages of RDN over pharmacological therapy?

Faculty Biographies

Patrick W Serruys

Patrick W Serruys

Prof Patrick W Serruys has been a senior interventional cardiologist since 1977, Chief of Interventional Research since 1988, the Chief of Interventional Cardiology at the Thorax Center from 1997-2012, and Prof. of Medicine till April 1st 2014 at Erasmus MC. In 2006, Prof Serruys and Prof John Ormiston developed fully biodegradable drug-eluting scaffolds.

Prof Serruys has won career achievement awards from the TCT, the American College of Cardiology, and the European Society of Cardiology. 

Currently, he is Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) of Imperial College in London (UK).

View full profile